| Tap a line for its trend | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21Mar 2021 | FY20 and earlierAlpha Plus |
|---|
| 158.25× | 138.99× | 140.43× | 161.25× | FY20 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 60.50× | 57.87× | 55.82× | 42.41× | ||
| 52.39× | 37.21× | 34.33× | 44.50× | ||
| 166.36× | 159.65× | 161.92× | 159.16× | ||
| 1.30× | 1.52× | 1.42× | 1.26× | ||
| 0.00× | 0.00× | 0.50× | 0.85× | ||
| 0.00× | 0.00× | 0.27× | 0.38× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY21 31/03/2021 | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | |
|---|---|---|---|---|---|
| Inventory Days (DIO) | 161.25 | 140.43 | 138.99 | 158.25 | |
| Receivable Days (DSO) | 42.41 | 55.82 | 57.87 | 60.50 | |
| Payable Days (DPO) | 44.50 | 34.33 | 37.21 | 52.39 | |
| Cash Conversion Cycle (days) | 159.16 | 161.92 | 159.65 | 166.36 | |
| Asset Turnover | 1.26 | 1.42 | 1.52 | 1.30 | |
| Cash Conversion (CFO/Net Income) | 0.85 | 0.50 | 0.00 | 0.00 | |
| CFO/EBITDA | 0.38 | 0.27 | 0.00 | 0.00 |